SIS
FOLD

Sound Income Strategies’s Amicus Therapeutics FOLD Stock Holding History

Sound Income Strategies’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-100
Closed -$816 – 1646
2025
Q1 		$816 Hold
100
– – ﹤0.01% 1372
2024
Q4 		$942 Hold
100
– – ﹤0.01% 1284
2024
Q3 		$1.07K Buy
+100
New +$1.09K ﹤0.01% 1239

Other funds holding FOLD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Sound Income Strategies's FOLD Position: Q2 2025 in Review

Sound Income Strategies sold out of Amicus Therapeutics (FOLD) in Q2 2025, closing a stake of 100 shares — an estimated $816 sold.

Sound Income Strategies first reported a position in FOLD in Q3 2024 and held it in 3 quarters. The position peaked at $1.07K in Q3 2024. 272 funds tracked by Wall St. Rank hold FOLD as of Q2 2025.

  • Sound Income Strategies reported no remaining Amicus Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Sound Income Strategies sold 100 Amicus Therapeutics shares in Q2 2025, an estimated $816.
  • Sound Income Strategies first reported a position in Amicus Therapeutics in Q3 2024 and held it in 3 quarters.
  • Sound Income Strategies's Amicus Therapeutics position peaked at $1.07K in Q3 2024.
  • 272 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2025.

Based on Sound Income Strategies's 13F filing for Q2 2025, filed 17 Jul 2025.